BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 27665050)

  • 1. Human Serum Metabolites Associate With Severity and Patient Outcomes in Traumatic Brain Injury.
    Orešič M; Posti JP; Kamstrup-Nielsen MH; Takala RSK; Lingsma HF; Mattila I; Jäntti S; Katila AJ; Carpenter KLH; Ala-Seppälä H; Kyllönen A; Maanpää HR; Tallus J; Coles JP; Heino I; Frantzén J; Hutchinson PJ; Menon DK; Tenovuo O; Hyötyläinen T
    EBioMedicine; 2016 Oct; 12():118-126. PubMed ID: 27665050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of serum chemokine-like factor 1 as a biomarker of severity and prognosis after severe traumatic brain injury: A prospective observational study.
    Wu X; Su C; Tian D; Ye Y; Du Q; Chen J; Li H; Liu J
    Brain Behav; 2024 May; 14(5):e3522. PubMed ID: 38773776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Glasgow Coma Scale score and pupil parameters on mortality rate and outcome in pediatric and adult severe traumatic brain injury: a retrospective, multicenter cohort study.
    Emami P; Czorlich P; Fritzsche FS; Westphal M; Rueger JM; Lefering R; Hoffmann M
    J Neurosurg; 2017 Mar; 126(3):760-767. PubMed ID: 27035177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery and validation of temporal patterns involved in human brain ketometabolism in cerebral microdialysis fluids of traumatic brain injury patients.
    Eiden M; Christinat N; Chakrabarti A; Sonnay S; Miroz JP; Cuenoud B; Oddo M; Masoodi M
    EBioMedicine; 2019 Jun; 44():607-617. PubMed ID: 31202815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simplifying the use of prognostic information in traumatic brain injury. Part 2: Graphical presentation of probabilities.
    Murray GD; Brennan PM; Teasdale GM
    J Neurosurg; 2018 Jun; 128(6):1621-1634. PubMed ID: 29631517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of neurofilament-H in serum as a diagnostic tool to predict injury severity in patients who have suffered mild traumatic brain injury.
    Gatson JW; Barillas J; Hynan LS; Diaz-Arrastia R; Wolf SE; Minei JP
    J Neurosurg; 2014 Nov; 121(5):1232-8. PubMed ID: 25192482
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Levels of Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 During the First Week After a Traumatic Brain Injury: Correlations With Clinical and Imaging Findings.
    Posti JP; Takala RS; Runtti H; Newcombe VF; Outtrim J; Katila AJ; Frantzén J; Ala-Seppälä H; Coles JP; Hossain MI; Kyllönen A; Maanpää HR; Tallus J; Hutchinson PJ; van Gils M; Menon DK; Tenovuo O
    Neurosurgery; 2016 Sep; 79(3):456-64. PubMed ID: 26963330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing Plasma Phospho Tau, Total Tau, and Phospho Tau-Total Tau Ratio as Acute and Chronic Traumatic Brain Injury Biomarkers.
    Rubenstein R; Chang B; Yue JK; Chiu A; Winkler EA; Puccio AM; Diaz-Arrastia R; Yuh EL; Mukherjee P; Valadka AB; Gordon WA; Okonkwo DO; Davies P; Agarwal S; Lin F; Sarkis G; Yadikar H; Yang Z; Manley GT; Wang KKW; ; Cooper SR; Dams-O'Connor K; Borrasso AJ; Inoue T; Maas AIR; Menon DK; Schnyer DM; Vassar MJ
    JAMA Neurol; 2017 Sep; 74(9):1063-1072. PubMed ID: 28738126
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of a prognostic score for early mortality in severe head injury cases.
    Gómez PA; de-la-Cruz J; Lora D; Jiménez-Roldán L; Rodríguez-Boto G; Sarabia R; Sahuquillo J; Lastra R; Morera J; Lazo E; Dominguez J; Ibañez J; Brell M; de-la-Lama A; Lobato RD; Lagares A
    J Neurosurg; 2014 Dec; 121(6):1314-22. PubMed ID: 25237737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum Metabolites Associated with Computed Tomography Findings after Traumatic Brain Injury.
    Dickens AM; Posti JP; Takala RSK; Ala-Seppälä H; Mattila I; Coles JP; Frantzén J; Hutchinson PJ; Katila AJ; Kyllönen A; Maanpää HR; Newcombe V; Outtrim J; Tallus J; Carpenter KLH; Menon DK; Hyötyläinen T; Tenovuo O; Orešic M
    J Neurotrauma; 2018 Nov; 35(22):2673-2683. PubMed ID: 29947291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNAs as Novel Biomarkers for the Diagnosis and Prognosis of Mild and Severe Traumatic Brain Injury.
    Di Pietro V; Ragusa M; Davies D; Su Z; Hazeldine J; Lazzarino G; Hill LJ; Crombie N; Foster M; Purrello M; Logan A; Belli A
    J Neurotrauma; 2017 Jun; 34(11):1948-1956. PubMed ID: 28279125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrative Analysis of Circulating Metabolite Profiles and Magnetic Resonance Imaging Metrics in Patients with Traumatic Brain Injury.
    Thomas I; Dickens AM; Posti JP; Mohammadian M; Ledig C; Takala RSK; Hyötyläinen T; Tenovuo O; Orešič M
    Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32092929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential of heart fatty-acid binding protein, neurofilament light, interleukin-10 and S100 calcium-binding protein B in the acute diagnostics and severity assessment of traumatic brain injury.
    Koivikko P; Posti JP; Mohammadian M; Lagerstedt L; Azurmendi L; Hossain I; Katila AJ; Menon D; Newcombe VFJ; Hutchinson PJ; Maanpää HR; Tallus J; Zetterberg H; Blennow K; Tenovuo O; Sanchez JC; Takala RSK
    Emerg Med J; 2022 Mar; 39(3):206-212. PubMed ID: 34916280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma miR-9-3p and miR-136-3p as Potential Novel Diagnostic Biomarkers for Experimental and Human Mild Traumatic Brain Injury.
    Das Gupta S; Ciszek R; Heiskanen M; Lapinlampi N; Kukkonen J; Leinonen V; Puhakka N; Pitkänen A
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33557217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Using metabolomics to predict severe traumatic brain injury outcome (GOSE) at 3 and 12 months.
    Banoei MM; Lee CH; Hutchison J; Panenka W; Wellington C; Wishart DS; Winston BW;
    Crit Care; 2023 Jul; 27(1):295. PubMed ID: 37481590
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simplifying the use of prognostic information in traumatic brain injury. Part 1: The GCS-Pupils score: an extended index of clinical severity.
    Brennan PM; Murray GD; Teasdale GM
    J Neurosurg; 2018 Jun; 128(6):1612-1620. PubMed ID: 29631516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of serum total tau following paediatric traumatic brain injury: a case-control study.
    Stukas S; Higgins V; Frndova H; Gill J; Hubara E; Guerguerian AM; Boutis K; Beauchamp M; Farrell C; Babl FE; Delzoppo C; Greenham M; Wilkinson AA; Crichton A; Anderson V; Adeli K; Hutchison J; Wellington C; ; ;
    Lancet Child Adolesc Health; 2019 Aug; 3(8):558-567. PubMed ID: 31231066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomics in severe traumatic brain injury: a scoping review.
    Fedoruk RP; Lee CH; Banoei MM; Winston BW
    BMC Neurosci; 2023 Oct; 24(1):54. PubMed ID: 37845610
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.